- Home
- BIPC vs FOLD Comparison
BIPC vs FOLD Comparison
Compare BIPC & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BIPC | FOLD |
|---|---|---|
| Founded | 2019 | 2002 |
| Country | United States | United States |
| Employees | 250000 | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.5B |
| IPO Year | 2019 | 2006 |
Fundamental Metrics
Financial Performance| Metric | BIPC | FOLD |
|---|---|---|
| Price | $37.38 | $14.49 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $45.00 | $27.25 |
| AVG Volume (30 Days) | 989.1K | ★ 2.4M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 5.13% | N/A |
| EPS Growth | N/A | ★ 50.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.85 | $20.50 |
| Revenue Next Year | $5.94 | $18.59 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $34.18 | $5.66 |
| 52 Week High | $51.72 | $14.50 |
Technical Indicators
Market Signals| Indicator | BIPC | FOLD |
|---|---|---|
| Relative Strength Index (RSI) | 35.85 | 74.18 |
| Support Level | N/A | $14.21 |
| Resistance Level | $40.93 | N/A |
| Average True Range (ATR) | 1.37 | 0.02 |
| MACD | -0.34 | -0.00 |
| Stochastic Oscillator | 37.42 | 100.00 |
Price Performance
Historical ComparisonAbout BIPC Brookfield Infrastructure Corporation
Brookfield Infrastructure Corp is an indirect subsidiary of the partnership of the diversified infrastructure owner and operators. Its business is comprised of a U.K. regulated distribution operation, a Brazilian regulated natural gas transmission operation and an international intermodal logistics operation. Geographically, the company generates a majority of its revenue from Brazil and rest from United Kingdom, United States, France, Switzerland, Singapore, China, Denmark, Hong Kong, Germany and Others.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.